+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Preparation, characterization and antimicrobial applications of Zn-Fe LDH against MRSA

Preparation, characterization and antimicrobial applications of Zn-Fe LDH against MRSA

Materials Science and Engineering. C, Materials for Biological Applications 68: 184-193

Facile and simple processes to get Zn-Fe layered double hydroxide (LDH) with nitrate as the interlayer anion are reported. The method of co-precipitation produced high crystallinity LDH that is marked by XRD, SEM, TEM and FT-IR. Results showed that 99.8% of Cd(+2) removals were at pH11 and 4h. To get the adsorption isotherms, the concentration of metal ions extending from 6 to 18mg/L was utilized. Results supported the Langmuir adsorption model. In contrary, the adsorption process followed the pseudo-second-order reaction kinetics. Interestingly, the prepared LDH shows durable antimicrobial activities against Gram-negative (Proteous vulgaris, Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pyogenes and MRSA) and fungi (Candida albicans, Aspergillus fumigatus, Geotricumcandidum, and Trichophyton mentagrophytes). The minimum inhibitory concentration (MIC) of Zn-Fe LDH varied from 0.49 to 15.60μg/mL according to the types of microorganisms. The prepared LDH achieved 90% at pH8.50 which is the pH of wastewater and at the same time exhibited durable antimicrobial activities against MRSA, Gram-negative, Gram-positive and fungi. Results have significant implications in the field of bioremediation of water with little cost, simple operation, high productivity and easiness of the equipment.

(PDF emailed within 0-6 h: $19.90)

Accession: 058609086

Download citation: RISBibTeXText

PMID: 27524011

DOI: 10.1016/j.msec.2016.05.110

Related references

Superior in vitro activity of carbapenems over anti-methicillin-resistant Staphylococcus aureus (MRSA) and some related antimicrobial agents for community-acquired MRSA but not for hospital-acquired MRSA. Journal of Infection and ChemoTherapy 15(1): 54-57, 2009

Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clinical Infectious Diseases 52(1): 99-114, 2011

Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. Journal of Clinical Microbiology 45(8): 2486-2490, 2007

N-Halamine-Based Antimicrobial Additives for Polymers: Preparation, Characterization and Antimicrobial Activity. Industrial and Engineering Chemistry Research 45(8): 2634-2640, 2008

Detection and genetic characterization of PVL-positive ST8-MRSA-IVa and exfoliative toxin D-positive European CA-MRSA-Like ST1931 (CC80) MRSA-IVa strains in Bangladesh. Microbial Drug Resistance 20(4): 325-336, 2015

Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage in residents of Veterans Affairs long-term care facilities: role of antimicrobial exposure and MRSA acquisition. Infection Control and Hospital Epidemiology 33(6): 551-557, 2012

Preparation, characterization and preliminary application of monoclonal antibody against the transpeptidase domain of MRSA-PBP2a. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23(6): 552-555, 2007

Evaluation of in-vitro antimicrobial activity of GAR-936 against community-acquired MRSA and hospital-acquired MRSA including strains resistant to vancomycin. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 159, 2002

Antimicrobial susceptibility against ceftizoxime among staphylococcus aureus resistant to methicillin mrsa and those susceptible mssa potential usage to discriminate between mrsa and mssa. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 226, 1992

Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections. Antimicrobial Resistance and Infection Control 2(1): 28, 2013

Preparation of antimicrobial reduced lysozyme compatible in food applications. Journal of Agricultural and Food Chemistry 51(17): 5154-5161, 2003

MRSA detection: comparison of two molecular methods (BD GeneOhm PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. European Journal of Clinical Microbiology and Infectious Diseases 28(1): 47-53, 2008

Development and characterization of MRSA-Specific human monoclonal antibodies for therapeutic and prophylactic treatment of MRSA infections. Abstracts of the General Meeting of the American Society for Microbiology 99: 274, 1999

Characterization of PVL/ACME-positive methicillin-resistant Staphylococcus aureus (genotypes ST8-MRSA-IV and ST5-MRSA-II) isolated from a university hospital in Japan. Microbial Drug Resistance 19(1): 48-56, 2013

Biosynthesis, characterization, and antimicrobial applications of silver nanoparticles. International Journal of Nanomedicine 10: 2567-2577, 2016